...
首页> 外文期刊>Medicinski Glasnik >Prevention of trismus with different pharmacological therapies after surgical extraction of impacted mandibular third molar
【24h】

Prevention of trismus with different pharmacological therapies after surgical extraction of impacted mandibular third molar

机译:下颌第三磨牙手术拔牙后不同药物疗法预防三叉戟

获取原文
           

摘要

Aim To assess prevention and reduction of trismus after surgicallyextracted impacted mandibular third molars with individualand combined therapy with corticosteroids and anti-inflammatoryanalgesics.Methods The research included 60 randomly selected patients (3groups) attended to the Dental Oral Surgery of the Public InstitutionHealthcare Center Zenica during the period January-December2008. Patients of both genders, 18-45 years of age, werepresented without pain and other inflammatory symptoms at thetime of surgery. According to a scheme established in the researchprotocol, two medications were administered orally: methylprednisolone(corticosteroid) 32 mg and meloxicam (non-steroidal anti-inflammatory analgesic, NSAID) 15 mg as a single drug, or acombination of both drugs. The level of trismus is assessed on thebasis of differences of preoperative and postoperative values of interincisalspaces when fully opening the mouth on the second andthe seventh post-operative day. The differences between groups ofpatients were evaluated by means of Tukey’s HSD test.Results On the second and on the seventh post-operative day significantlybetter results were registered in the group that receivedonly corticosteroids and in the group that received both, corticosteroidsand NSAIDs compared to the group that received onlyNSAIDs. A tendency of trismus reduction was present in all patientgroups for the second and seventh day after surgery.Conclusion Prevention and control of postoperative trismus aftersurgical extraction of impacted mandibular third molars with combinedtherapy is effective and superior comparing to individualtherapy with meloxicam-or methylprednisolone alone
机译:目的评估单独和结合皮质类固醇和抗炎镇痛药联合手术切除下颌第三磨牙的手术摘除的预防和减少方法。该研究包括60名随机选择的患者(3组),在此期间接受了公共机构Zenica保健中心的口腔外科手术。 2008年1月至12月。年龄在18-45岁之间的男女患者在手术时均未出现疼痛和其他炎症症状。根据研究方案中建立的方案,口服两种药物:单药或两种药物的组合分别口服32 mg甲基强的松龙(皮质类固醇)和15 mg的美洛昔康(非甾体类抗炎镇痛药,NSAID)。在手术后第二天和第七天完全张开嘴时,根据牙间间隙的术前和术后值的差异来评估三头肌的水平。结果:在术后第二天和第七天,仅接受皮质类固醇治疗的患者和接受皮质类固醇和非甾体抗炎药治疗的患者相比,两组患者之间的差异显着更好。仅收到NSAID的广告。结论术后第二天和第七天所有患者组均出现三头肌减少的趋势。结论与单独使用美洛昔康或甲基强的松龙单独治疗相比,预防和控制术后下颌第三磨牙的拔除术后三头肌有效且优于其他疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号